Plataforma para la divulgaci�n cient�fica de los beneficios de
los �cidos grasos Omega-3

• Sus expertos en Omega-3

• El Omega-3

• Beneficios del Omega-3

• La opinión de los expertos

• Noticias

• Estudios Omega-3

• Artículos

16/03/2011 - Publicado en Omega-3 Summit imprimir 

Acuerdo un�nime de la cumbre Global Summit on Nutrition, Health and Human Behaviour

Autor: Health Claims Europe  
Fecha: 4/03/2011

Sinopsis:
Las conclusiones del encuentro “Global Summit on Nutrition, Health and Human Behaviour”, celebrado en Bruselas (3 y 4 de marzo), abogan por invertir más recursos para concienciar a Gobiernos, profesionales de la salud y público general sobre la necesidad de paliar los déficits de Omega-3 que repercuten en los desórdenes cognoscitivos. Entre las recomendaciones acordadas, apuestan por el equilibrio entre Omega-3 y Omega-6 , así como la necesidad de obtener Omega-3 (especialmente DHA ) de una manera sostenible.


ARTÍCULO:

Global Omega‐3 Summit Unanimously Signs Consensus Statements

The omega‐3 industry must devote more resources to lobbying and educating government, health care professionals and the general public to help plug a ‘policy gap’ that is contributing to a growing epidemic of cognitive.
A consensus document from stakeholders and academics was agreed and signed by attendees of the Omega‐3 Summit:

‐Brain and heart disorders resulting from LC‐Omega‐3 (EPA+DHA) deficiency are the biggest challenges to the future of humanity

• Associated costs are currently bankrupting health care systems and threatening wider economic instability worldwide.

‐Tissue concentrations of LC‐Omega‐3 (relative to LC‐Omega‐6) are the key variable for health – not dietary intakes.

• Biomarkers need to be standardised and used as public health targets
• Omega‐3 Index 8‐11, Omega‐3 in HUFA 50%+ would protect 98% of population

‐Dietary intake of >1000mg LC‐Omega‐3 needed if consuming western‐type diet (but this depends on dietary % LA vs. ALA, and ARA)

• Most people fall far short of these basic needs

‐Shorter-Chain Omega-3 (ALA, SDA and EPA) have poor conversion to DHA in humans
‐To make tissue targets feasible, we urgently need to

• Reduce LA and increase ALA in human and animal diets
• Increase the availability of LC‐Omega‐3 (especially DHA) for human consumption in a sustainable, environmentally responsible way

‐Education of all stakeholders is key to achieving these changes.